2017
DOI: 10.3390/chemosensors5020013
|View full text |Cite
|
Sign up to set email alerts
|

Electrochemical Immunosensors and Aptasensors

Abstract: Since the first electrochemical biosensor for glucose detection, pioneered in 1962 by Clark and Lyons [1], research and application in the field has grown at an impressive rate and we are still witnessing a continuing evolution of research on this topic [2].[...]

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
5
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 23 publications
0
5
0
Order By: Relevance
“…The high specificity provided by antigen–antibody recognition has fueled the development of electrochemical immunosensors 80,81. As for enzyme-based electrochemical biosensors, considerable efforts have been invested into the integration of this class of sensors within microfluidic platforms.…”
Section: Electrochemical Biosensorsmentioning
confidence: 99%
See 1 more Smart Citation
“…The high specificity provided by antigen–antibody recognition has fueled the development of electrochemical immunosensors 80,81. As for enzyme-based electrochemical biosensors, considerable efforts have been invested into the integration of this class of sensors within microfluidic platforms.…”
Section: Electrochemical Biosensorsmentioning
confidence: 99%
“…The high specificity provided by antigen–antibody recognition has fueled the development of electrochemical immunosensors. , As for enzyme-based electrochemical biosensors, considerable efforts have been invested into the integration of this class of sensors within microfluidic platforms. Moreover, a large variety of functionalization strategies has been developed to ensure effective and reproducible antibody immobilization on the sensor electrode …”
Section: Electrochemical Biosensorsmentioning
confidence: 99%
“…Up to now, some analysis techniques have been used to detect MUC1, such as fluorescence, , electrochemiluminescence, , surface plasmon resonance (SPR), , surface enhanced Raman spectroscopy (SERs), enzyme-linked immunosorbent assay, and electrochemical techniques. Particularly, the electrochemical detection techniques have attracted a lot of attention due to the simplicity of the equipment and high sensitivity. The electrochemical detection techniques can be classified into two main groups named electrochemical aptasensors and electrochemical immunosensors according to the identified elements of sensor substrates . Electrochemical aptasensors are very promising for the early determination of cancer as they are inexpensive, rapid, portable, direct, selective, and sensitive to their target. , Until now, several electrochemical aptasensors have been used for MUC1 assay.…”
Section: Introductionmentioning
confidence: 99%
“…The electrochemical detection techniques can be classified into two main groups named electrochemical aptasensors and electrochemical immunosensors according to the identified elements of sensor substrates. 18 Electrochemical aptasensors are very promising for the early determination of cancer as they are inexpensive, rapid, portable, direct, selective, and sensitive to their target. 19,20 Until now, several electrochemical aptasensors have been used for MUC1 assay.…”
Section: Introductionmentioning
confidence: 99%
“…Immunoassays are a principal analytical technique in bioanalysis constructed by the formation of an immunocomplex between an antigen and antibody, which uses different labels like radioactive isotopes, enzymes, and fluorophores for signal development. Currently, these molecular labels are gradually being replaced by functional composite nanomaterials since they have tremendous optical and catalytic properties or biological activities and enhanced chemical stability. Numerous nanomaterial-based immunoassays have been developed for the detection of various biological and chemical targets such as cells, proteins, pathogens, and small molecular toxins. Presently, according to the labels used, immunoassays are of several types, including enzyme-linked immunosorbent assay (ELISA), ,, radioimmunoassay (RIA), , electrophoretic immunoassay (EIA), colorimetric immunoassay, , fluorescence immunoassay (FIA), , chemiluminescence immunoassay (CLIA), , electrochemical immunoassay (ECIA), and electrochemiluminescence immunoassay (ECLIA). Among them, ECLIA has been paid excited attention in clinical practice due to its high sensitivity, specificity, easy operation, and low background signal, and it does not require any radioactive materials. For instance, ECLIA has been successfully applied to detect various targets in 50–150 μL of serum sample with the limit of detection (LOD) up to picomolar concentration. Though, the concentration of some target analytes associated with early cancer or infectious diseases found in the blood serum and plasma samples of patients is <10 –15 mol/L. , Thus, the development of an ultrasensitive ECLIA for the selective detection of trace biological analytes in real samples is highly challenging.…”
mentioning
confidence: 99%